Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
Status:
Recruiting
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
To determine the effectiveness of using two medications simultaneously versus one medication,
as is standard of care, in preventing early postpartum hemorrhage.
There have been studies that looked at giving two medications and that there were reduced
odds of postpartum hemorrhage.
Specific Aim 1: Determine if double simultaneous uterotonic agent regimen (misoprostol and
oxytocin) is superior to single agent (oxytocin only) in reducing postpartum hemorrhage.
Specific Aim 2: Determine any potential side effects of a double simultaneous uterotonic
agentregimen (misoprostol and oxytocin) versus a single agent (oxytocin only).